CARDIAC RSK3 INHIBITORS, LLC
Los Altos, United States · Founded 2019 · $4.2M raised
- Headquarters
- Los Altos, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Total Funding
- $4.2M
- Last Round
- $2.0M GrantJul 2024
About
Cardiac RSK3 Inhibitors LLC is an early-stage biopharmaceutical company developing novel biologic drugs for heart failure by targeting RSK3, a kinase that regulates pathological cardiac remodeling. Founded by Dr. Michael Kapiloff, the company is advancing an adeno-associated virus (AAV) gene therapy vector expressing an RSK3 anchoring disruptor peptide that blocks the mAKAP-RSK3 signaling complex implicated in heart failure progression.
Summary
CARDIAC RSK3 INHIBITORS, LLC is a Biotech company based in Los Altos, United States, founded in 2019. It has raised $4.2M in total, most recently a $2.0M Grant round in Jul 2024.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.